Amylou C. Dueck

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 48 papers. Top paper: “Preoperative Treatment of Locally Advanced Rectal Cancer”.

Preoperative Treatment of Locally Advanced Rectal Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2303269

N/A

5.6DataRank · unranked

460 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +20 more

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

British Journal of Cancer(2020)10.1038/s41416-020-0786-x

N/A

1.4DataRank · unranked

40 citations

Noam Pondé, Dominique Agbor‐Tarh, Alvaro Moreno‐Aspitia, Martine Piccart, Florentine Hilbers +11 more

An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment

Value in Health(2022)10.1016/j.jval.2021.11.1368

N/A

0.870DataRank · unranked

18 citations

Ethan Basch, Carolyn Mead‐Harvey, Antonia V. Bennett, Gina L. Mazza, Gisela Schwab +4 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

npj Breast Cancer(2022)10.1038/s41523-022-00430-0

N/A

0.417DataRank · unranked

8 citations

Zhuo Li, Daniel Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner +20 more

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3641

N/A

0.353DataRank · unranked

6 citations

Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese +6 more

Implementation of Symptom Monitoring With Electronic Patient-Reported Outcomes: Perspectives and Recommendations From Community Oncology Practices (Alliance AFT-39)

JCO Oncology Practice(2025)10.1200/op-24-00627

N/A

0.329DataRank · unranked

6 citations

Antonia V. Bennett, Angela M. Stover, Mattias Jönsson, Randall Teal, Maihan B. Vu +7 more

Integrating 4 Measures to Evaluate Physical Function in Patients with Cancer (In4M): Protocol for a prospective study

medRxiv(2023)10.1101/2023.03.08.23286924

N/A

0.287DataRank · unranked

4 citations

Paul G. Kluetz, Vishal Bhatnagar, Abbie Brown, Elizabeth Cathcart-Rake, Matthew Diamond +16 more

Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

Cancers(2025)10.3390/cancers17213459

N/A

0.269DataRank · unranked

5 citations

Sandra A. Mitchell, Ethan Basch, Allison M. Deal, Blake Langlais, Gita Thanarajasingam +8 more

Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE ® ) in a diverse cancer sample

Clinical Trials(2024)10.1177/17407745241286065

N/A

0.208DataRank · unranked

3 citations

Ethan Basch, Lauren Rogak, Blake Langlais, Gita Thanarajasingam, Brenda Ginos +10 more

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

BMC Medical Research Methodology(2025)10.1186/s12874-025-02617-y

N/A

0.165DataRank · unranked

2 citations

Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more

Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5107

N/A

0DataRank · unranked

4 citations

Glenn Heller, Charles J. Ryan, David James VanderWeele, Lionel D. Lewis, Alan Tan +10 more

Type 1 interferon perturbates clonal competition by reshaping human blood development

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.28.509751

N/A

0DataRank · unranked

2 citations

Danielle Isakov, Shira Rosenberg, Miguel Quijada-Álamo, Mirca Saurty-Seerunghen, Sara Moein +31 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms

Cancer(2023)10.1002/cncr.34800

N/A

0DataRank · unranked

8 citations

Heidi Kosiorek, Amylou C. Dueck, Jeanne Palmer, Lisa Sproat, James M. Bogenberger +6 more

Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD)

Clinical Trials(2023)10.1177/17407745231167123

N/A

0DataRank · unranked

1 citations

Amylou C. Dueck, George J. Chang, Selina Chow, Electra D. Paskett, Simon Kim +2 more

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba2

N/A

0DataRank · unranked

18 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +15 more

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4191

N/A

0DataRank · unranked

5 citations

Kimberly Perez, Susan M. Geyer, Maged Khalil, Aishwarya Vijendran, Andrea Kordaris-Corkill +9 more

Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1541

N/A

0DataRank · unranked

1 citations

Heather Gunn, Anne Barber, Lisa M. Lowenstein, Daniel Dohan, Jenny Broering +11 more

Geriatric pre-surgical optimization in the NCORP (Alliance).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.370

N/A

0DataRank · unranked

0 citations

Heather Gunn, Anne Barber, Lisa M. Lowenstein, Daniel Dohan, Jeanette M. Broering +14 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102838

N/A

0DataRank · unranked

18 citations

Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill A. Bell, Vishal Bhatnagar +27 more

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

Quality of Life Research(2024)10.1007/s11136-024-03675-3

N/A

0DataRank · unranked

17 citations

Amylou C. Dueck, Brenda Ginos, Jennifer Jansen, Allison M. Deal, Philip Carr +9 more

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma

Scientific Reports(2024)10.1038/s41598-024-62307-5

N/A

0DataRank · unranked

10 citations

Karen Keating, Brian J. Cuffel, Cem Elbi, Jonathan Siegel, Christoph Gerlinger +8 more

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

Cancer(2024)10.1002/cncr.35663

N/A

0DataRank · unranked

3 citations

Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix, W. Jeffrey Petty +5 more

Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)—Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD)

Annals of Surgery(2024)10.1097/sla.0000000000006458

N/A

0DataRank · unranked

4 citations

Heather Gunn, Anne K. Barber, Lisa M. Lowenstein, Daniel Dohan, Jeanette M. Broering +8 more

Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2356058

N/A

0DataRank · unranked

3 citations

Amylou C. Dueck, Heidi Kosiorek, Carolyn Mead‐Harvey, Eric A. Meek, Lauren J. Rogak +9 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

UNC Libraries(2024)10.17615/ypmf-1g37

N/A

0DataRank · unranked

0 citations

Melanie Calvert, Steven Rizk, Philip Collis, Alastair Greystoke, Bellinda L. King‐Kallimanis +27 more

Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

Contemporary Clinical Trials Communications(2025)10.1016/j.conctc.2025.101547

N/A

0DataRank · unranked

8 citations

Jamie K. Forschmiedt, Ethan Basch, Gina L. Mazza, Minji K. Lee, Eric A. Meek +8 more

Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae047

N/A

0DataRank · unranked

7 citations

Pedro A. Torres‐Saavedra, Eva Culakova, Heather Gunn, Minji K. Lee, Fenghai Duan +5 more

Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era

The Lancet Haematology(2025)10.1016/s2352-3026(25)00035-3

N/A

0DataRank · unranked

6 citations

Amylou C. Dueck, Gita Thanarajasingam, Ajay Major

Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series

The Lancet Haematology(2025)10.1016/s2352-3026(25)00027-4

N/A

0DataRank · unranked

4 citations

Ajay Major, Vishal Bhatnagar, Amylou C. Dueck, Karin E. Smedby, Tarec Christoffer El‐Galaly +8 more

Development and Validation of Emoji Response Scales for Assessing Patient-Reported Outcomes

JCO Clinical Cancer Informatics(2025)10.1200/cci-24-00148

N/A

0DataRank · unranked

2 citations

Paul J. Novotny, Kathleen J. Yost, Alicia Bartz, Lauren Rogak, Amylou C. Dueck +1 more

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

The Lancet Oncology(2020)10.1016/s1470-2045(19)30790-9

N/A

0DataRank · unranked

311 citations

Madeline Pe, Amylou C. Dueck, Jeff A. Sloan, Ethan Basch, Melanie Calvert +30 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

UNC Libraries(2025)10.17615/kfcn-nf74

N/A

0DataRank · unranked

0 citations

Afshin Mashadi-Hossein, Kathleen Tenner, Lisa A. Carey, Zhuo Li, Heather Ann Brauer +20 more

Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer

Annals of Oncology(2020)10.1016/j.annonc.2019.09.003

N/A

0DataRank · unranked

42 citations

Nora Horick, Allison M. Deal, Lauren J. Rogak, Charn‐Xin Fuh, Joseph A. Greer +5 more

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30067-3

N/A

0DataRank · unranked

29 citations

John P. Leonard, Thomas E. Witzig, Thomas M. Habermann, Kristie A. Blum, Nancy L. Bartlett +8 more

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7018

N/A

0DataRank · unranked

5 citations

Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears +15 more

Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol - A191402CD - A Cluster-Randomized Trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e24176

N/A

0DataRank · unranked

0 citations

Joel E. Pacyna, Daniel G. Petereit, Judith S. Kaur, Bruce D. Rapkin, Robert L. Grubb +15 more

The impact of within-visit and pre-visit decision aids for localized prostate cancer on patient knowledge.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.151

N/A

0DataRank · unranked

0 citations

Joel E. Pacyna, Kristin Cina, Daniel G. Petereit, Judith S. Kaur, Elizabeth M. Storrrick +4 more

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

UNC Libraries(2020)10.17615/7093-t942

N/A

0DataRank · unranked

0 citations

Sandra A. Mitchell, Amylou C. Dueck, Carolyn M. Reilly, Bryce B. Reeve, Ethan Basch +3 more

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials

BMJ Open(2021)10.1136/bmjopen-2020-045105

N/A

0DataRank · unranked

136 citations

Madeleine King, Rebecca Mercieca‐Bebber, Olalekan Lee Aiyegbusi, Derek Kyte, Anita Slade +41 more

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D)

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06409-y

N/A

0DataRank · unranked

0 citations

Dominique Agbor‐Tarh, Lissandra Dal Lago, Larissa A. Korde, Florentine Hilbers, Christian Jackisch +9 more

Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.004

N/A

0DataRank · unranked

65 citations

Amylou C. Dueck, Gita Thanarajasingam, Joan M. Griffin, Carrie A. Thompson, Urshila Durani +12 more

Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo as novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps194

N/A

0DataRank · unranked

5 citations

Glenn Heller, Charles J. Ryan, David James VanderWeele, Lionel D. Lewis, Alan Tan +10 more

Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19078

N/A

0DataRank · unranked

5 citations

Gina L. Mazza, Robyn M. Scherber, Holly L. Geyer, Krisstina Gowin, Jeanne Palmer +6 more

Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (Alliance, Sub-study CALGB 70702).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8504

N/A

0DataRank · unranked

4 citations

Amylou C. Dueck, Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix +3 more